1. Research Objectives and Assumptions

   • Research Objectives
   • Assumptions
   • Abbreviations

2. Market Purview

   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snapshot, By Drug Class
     • Market Snapshot, By Region
   • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

   • Market Dynamics
     • Increasing prevalence of hyperlipidemia worldwide
     • High cost of treatment and lack of awareness
     • Increasing demand for antihyperlipidemic drugs
   • Impact Analysis
   • Key Highlights
   • Regulatory Scenario
   • Product launch/Approvals
   • PEST Analysis
   • PORTER’s Analysis
   • Merger and Acquisition Scenario

4. Global Antihyperlipidemic Drugs Market, By Drug Class, 2021 - 2033, (US$ Bn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022 – 2033
     • Segment Trends
   • Statins
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
   • Bile Acid Sequestrants
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
   • Cholesterol Absorption Inhibitors
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
   • Fibric Acid Derivatives
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
   • PCSK9 Inhibitors
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
   • Combination
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

5. Global Antihyperlipidemic Drugs Market, By Region, 2021 - 2033, (US$ Bn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022 – 2033
     • Segment Trends
   • North America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033,(US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
       • U.S.
       • Canada
   • Latin America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033,(US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
       • Brazil
       • Argentina
       • Mexico
       • Rest of Latin America
   • Europe
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033,(US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
       • Germany
       • U.K.
       • Spain
       • France
       • Italy
       • Russia
       • Rest of Europe
   • Asia Pacific
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033,(US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
       • China
       • Japan
       • India
       • Australia
       • South Korea
       • ASEAN
       • Rest of Asia Pacific
   • Middle East
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033,(US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
       • GCC Countries
       • Israel
       • Rest of Middle East
   • Africa
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033,(US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
       • South Africa
       • North Africa
       • Central Africa

6. Competitive Landscape

   • Sanofi S.A.
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Pfizer Inc.
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Mylan N.V.
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Amgen Inc.
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Abbvie Inc.
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Merck & Co., Inc.
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Dr. Reddy’s Laboratories Ltd.
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Bristol-Myers Squibb Company
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • AstraZeneca plc
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Daiichi Sankyo Company
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Analyst Views

7. Section

   • Research Methodology
   • About us